Table 2.
Outcome Measure | Order | Ketaminea | Placeboa | First vs. Second Dayd | Drug by Order Effecte |
---|---|---|---|---|---|
Category criteria met | Ketamine firstb | 1.5 ± .7f | 4.8 ± .6 | t9 = 5.7, p = .0003 | p = .003 |
Placebo firstc | 4.5 ± .7 | 5.1 ± .4 | ns | ||
Percent perseverative errors | Ketamine first | 69.2 ± 5.5g | 53.1 ± 3.6 | t9 = 3.3, p = .009 | p = .03 |
Placebo first | 49.2 ± 3.6 | 46.0 ± 3.6 | ns | ||
Perseverative errors | Ketamine first | 53.4 ± 8.6h | 21.8 ± 5.9 | t9 = 4.2, p = .002 | p = .004 |
Placebo first | 19.3 ± 3.8 | 13.8 ± 3.9 | ns | ||
Total errors | Ketamine first | 74.0 ± 8.1f | 37.8 ± 7.4 | t9 = 5.4, p = .0004 | p = .005 |
Placebo first | 42.8 ± 8.4 | 27.7 ± 6.5 | ns | ||
Number of items | Ketamine first | 124.6 ± 3.4h | 110.0 ± 4.8 | t9 = 3.3, p = .009 | p = .04 |
Placebo first | 112.4 ± 5.5 | 101.0 ± 7.9 | ns | ||
Trials to first criterion | Ketamine first | 21.9 ± 10.4 | 20.8 ± 3.3 | ns | ns |
Placebo first | 14.3 ± 3.2 | 23.4 ± 5.7 | ns | ||
Loss of set | Ketamine first | 1.2 ± .5 | 1.3 ± .6 | ns | ns |
Placebo first | .9 ± .3 | 1.5 ± .6 | ns |
Data are presented as mean ± SEM.
Ketamine first subjects received ketamine on the first test day and placebo on the second test day (n = 10).
Placebo first subjects received placebo on the first test day and ketamine on the second test day (n = 12).
Two-tailed post hoc paired t tests comparing subjects on their first and second test days. All post hoc tests underwent Bonferroni adjustments.
Significance of the drug by time interaction effect in the repeated measures ANOVA, see text for other analyses. Two-tailed post hoc Student’s t tests comparing groups of subjects on the same test day:
p ≤ .005;
p ≤ .05;
p ≤ .01.